Cite
HARVARD Citation
Kemaladewi, D. et al. (2019). Development of therapeutic genome engineering in laminin-α2-deficient congenital muscular dystrophy. Emerging topics in life sciences. 3 (1), pp. 11-18. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kemaladewi, D. et al. (2019). Development of therapeutic genome engineering in laminin-α2-deficient congenital muscular dystrophy. Emerging topics in life sciences. 3 (1), pp. 11-18. [Online].